| Literature DB >> 11460586 |
R G Bretzel1, M Brendel, M Eckhard, D Brandhorst, C Jaeger, E Hatziagelaki, K Federlin.
Abstract
Beta-cell replacement either by pancreatic organ or islet cell transplantation is the only treatment to achieve an insulin-independent, normoglycemic state and to avoid hypoglycemic episodes in patients with type 1 diabetes mellitus. This article will review the state-of-the-art in clinical islet cell transplantation at the dawn of the new millennium and will provide an outlook on the basis of extended personal experience.Entities:
Mesh:
Year: 2001 PMID: 11460586 DOI: 10.1055/s-2001-18597
Source DB: PubMed Journal: Exp Clin Endocrinol Diabetes ISSN: 0947-7349 Impact factor: 2.949